Health Care

Cheryl joined SDC March 2021. She specializes in investments in biopharmaceuticals, healthcare tech and medical device sectors. Prior to joining SDC, Cheryl co-founded a biotechnology start-up, Agropeutix, Inc., where she held both research and business development positions. She led research…

Robin joined Sixty Degree Capital in November 2019. Prior to joining, Robin worked for Toronto healthcare startups AmacaThera and Focal Healthcare in both business development and fundraising roles. Previously, Robin worked for ApoPharma’s pre-clinical research division as well as also…

Tyler began investing for Sixty Degree as an Associate at the start of 2021 before being promoted to Principal in 2022. Prior to working for SDC, he worked as an early employee of Edesa Biotech, a Toronto-based dermatology biopharma startup.…

Sintia is a Principal at Sixty Degree Capital who joined the team as an Investment Analyst in May 2021. Sintia earned her PhD in Immunology from the University of Toronto where she worked on autoimmune diseases such as colitis disease…

Nate is a Principal at Sixty Degree Capital who joined the team as an Investment Analyst in February 2022. Prior to joining, Nate completed a postdoctoral fellowship in the department of Chemistry at the University of British Columbia. He studied…

Ken is a Principal at Sixty Degree Capital who joined the team as an Investment Analyst in May 2021 . He acts as a science and market expert to help develop Sixty Degree Capital’s biotechnology and healthcare investment portfolio. Previously,…